Yahoo Web Search

Search results

1. www.nejm.org › doi › fullBreast-Cancer Adjuvant Therapy with Zoledronic Acid | New ...

   www.nejm.org › doi › full

   Oct 13, 2011 · Coleman, R, Woodward, E, Brown, J, et al. Safety of zoledronic acid and incidence of osteonecrosis of the jaw (ONJ) during adjuvant therapy in a randomised phase III trial (AZURE: BIG 01-04)...

   • Author: Robert E. Coleman, Helen Marshall, David Cameron, David Dodwell, Roger Burkinshaw, Maccon Keane, Mig...

   • Publish Year: 2011

2. www.onclive.com › view › dr-coleman-on-findings-fromDr. Coleman on Findings From the AZURE Trial for Breast ...

   www.onclive.com › view › dr-coleman-on-findings-from

   • Cached

   Jan 7, 2017 · Robert E. Coleman, MBBS, MD, FRCP, FRCPE, professor of Medical Oncology and head of the Academic Unit of Clinical Oncology at the University of Sheffield, discusses the safety findings from the...

3. www.thelancet.com › journals › lanoncAdjuvant zoledronic acid in patients with early breast cancer ...

   www.thelancet.com › journals › lanonc

   Adjuvant zoledronic acid in patients with early breast cancer: final efficacy analysis of the AZURE (BIG 01/04) randomised open-label phase 3 trial Prof Robert Coleman, FRCP Robert Coleman

   • Author: Robert Coleman, David Cameron, David Dodwell, Richard Bell, Caroline Wilson, Emma Rathbone, Emma Rat...

   • Publish Year: 2014

4. pubmed.ncbi.nlm.nih.gov › 25035292Adjuvant zoledronic acid in patients with early ... - PubMed

   pubmed.ncbi.nlm.nih.gov › 25035292

   Adjuvant zoledronic acid in patients with early breast cancer: final efficacy analysis of the AZURE (BIG 01/04) randomised open-label phase 3 trial. Lancet Oncol. 2014 Aug;15 (9):997-1006. doi: 10.1016/S1470-2045 (14)70302-X. Epub 2014 Jul 15. Authors.

   • Author: Robert Coleman, David Cameron, David Dodwell, Richard Bell, Caroline Wilson, Emma Rathbone, Emma Rat...

   • Publish Year: 2014

5. www.sciencedirect.com › science › articleBenefits and risks of adjuvant treatment with zoledronic acid ...

   www.sciencedirect.com › science › article

   Nov 1, 2018 · Adjuvant bisphosphonates improve disease outcomes in postmenopausal early breast cancer (EBC) but the long-term effects are poorly described. The AZURE trial (ISRCTN79831382) was designed to determine whether adjuvant zoledronic acid (ZOL) improves disease outcomes in EBC.

   • Author: R.E. Coleman, M. Collinson, W. Gregory, H. Marshall, R. Bell, D. Dodwell, M. Keane, M. Gil, P. Barre...

   • Publish Year: 2018

6. Videos

   • 

     10:41

     youtube.com

     Build your own copilots with Azure AI Studio

     Dec 11, 2023

     79.3K Views

   • 

     1:52

     youtube.com

     Introducing Microsoft Azure Boost

     Nov 15, 2023

     5.4K Views

   • 

     2:30:52

     youtube.com

     AZ-900 Azure Fundamentals Exam Cram (2024 Edition) - Full Course

     Jan 11, 2024

     100.1K Views

   View all

7. www.imdb.com › name › nm4692556Azure Coleman - IMDb

   www.imdb.com › name › nm4692556

   • Cached

   Azure Coleman is known for Knifed Up (2014), Hating Obama (2014) and When the Checks Stop Coming In (2014). Add photos, demo reels. Add to list. More at IMDbPro. Contact info. Agent info. Known for: Knifed Up. Producer. 2014. Hating Obama. 3.9. Producer. 2014. When the Checks Stop Coming In. 7.8. Producer. 2014. Toya: A Family Affair. 7.5.

8. www.thelancet.com › journals › lancetAdjuvant bisphosphonate treatment in early ... - The Lancet

   www.thelancet.com › journals › lancet

   on behalf of the AZURE investigators Adjuvant zoledronic acid in patients with early breast cancer: final efficacy analysis of the AZURE (BIG 01/04) randomised open-label phase 3 trial.